Top
AIM2 has not been detected as a mutational cancer driver

AIM2
Ensembl id ENSG00000163568
Mutated samples
Coding Sequence 42 (0.6%)
Protein Affecting 29 (0.4%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all AIM2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 13 7 1.90
Prostate adenocarcinoma No 4 4 1.65
Lung adenocarcinoma No 5 4 1.02
Breast carcinoma No 2 2 0.17
Lung squamous cell carcinoma No 3 2 1.15
Pancreas adenocarcinoma No 2 2 0.93
Serous ovarian adenocarcinoma No 2 2 0.63
Bladder carcinoma No 1 1 1.02
Uterine corpus endometrioid carcinoma No 1 1 0.43
Stomach adenocarcinoma No 1 1 0.62
Small cell lung carcinoma No 1 1 1.45
Head and neck squamous cell carcinoma No 1 1 0.27
Glioblastoma multiforme No 1 1 0.26
Hepatocarcinoma No 1 0 0.00
Chronic lymphocytic leukemia No 1 0 0.00
Lower grade glioma No 2 0 0.00
Pylocytic astrocytoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence